Go Pro
OTCMKTS:TRXDW

TransEnterix (TRXDW) Stock Price, News & Analysis

TransEnterix logo
$0.15 0.00 (0.00%)
As of 09/23/2026

About TransEnterix Stock (OTCMKTS:TRXDW)

Advanced

Key Stats

Today's Range
$0.15
▼
$0.15
50-Day Range
$0.15
▼
$0.15
52-Week Range
$0.12
▼
$0.18
Volume
N/A
Average Volume
8,250 shs
Market Capitalization
$21.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

TransEnterix, Inc. was a medical device company focused on developing and commercializing minimally invasive surgical technologies. The company’s principal product was the Senhance Surgical System, a digitally enabled laparoscopic platform designed to assist surgeons with visualization, instrument control, ergonomics and precision during minimally invasive procedures.

The Senhance system was developed for use across a range of laparoscopic specialties, including general surgery, gynecology and urology. TransEnterix pursued regulatory clearances and commercial opportunities in the United States and international markets, including Europe and Japan, and supported hospitals with related instruments, accessories and digital surgical technology.

In 2020, TransEnterix changed its corporate name to Asensus Surgical, Inc. to reflect its broader focus on digital surgery and the Senhance platform. The company was led by Todd M. Pope during much of its TransEnterix period, followed by Anthony Fernando as president and chief executive officer of Asensus Surgical. TransEnterix is therefore primarily associated with the company’s historical operations and the development of technology later marketed under the Asensus Surgical name.

AI Generated. May Contain Errors.

Receive TRXDW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TransEnterix and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TRXDW Stock News Headlines

Life Science Partners L P Synergy's Net Worth
Asensus Surgical Inc (ASXC)
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel
TransEnterix, Inc. (TRXDW)
Surgical Robots Global Market Report 2023
Asensus Surgical (NYSEMKT: ASXC)
See More Headlines

TRXDW Stock Analysis - Frequently Asked Questions

TransEnterix's stock was trading at $0.15 at the beginning of the year. Since then, TRXDW stock has increased by 0.0% and is now trading at $0.15.

TransEnterix, Inc. (OTCMKTS:TRXDW) announced its quarterly earnings results on Thursday, November, 5th. The medical instruments supplier reported ($0.12) earnings per share for the quarter, beating analysts' consensus estimates of ($0.23) by $0.11. The medical instruments supplier earned $0.81 million during the quarter, compared to analyst estimates of $0.73 million. TransEnterix had a negative trailing twelve-month return on equity of 83.74% and a negative net margin of 2,149.15%.

Shares of TRXDW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/05/2020
Today
9/25/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
OTCMKTS:TRXDW
CIK
876378
Fax
N/A
Employees
170
Year Founded
2006

Profitability

EPS (Trailing Twelve Months)
($4.22)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$154.20 million
Net Margins
-2,149.15%
Pretax Margin
N/A
Return on Equity
-83.74%
Return on Assets
-64.94%

Debt

Debt-to-Equity Ratio
0.04
Current Ratio
3.24
Quick Ratio
2.30

Sales & Book Value

Annual Sales
$8.53 million
Price / Sales
2.51
Cash Flow
$0.11 per share
Price / Cash Flow
1.40
Book Value
$2.68 per share
Price / Book
0.06

Miscellaneous

Outstanding Shares
142,777,000
Free Float
N/A
Market Cap
$21.42 million
Optionable
Not Optionable
Beta
2.56

Social Links

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (OTCMKTS:TRXDW) was last updated on 9/25/2026 by MarketBeat.com Staff.
From Our Partners